Group 1 - The company plans to establish a wholly-owned subsidiary in Vietnam to enhance its global strategy and expand its international market presence [1] - The subsidiary will be set up by the company's wholly-owned Singapore subsidiary, TOUA TECHNOLOGY PTE. LTD. [1] - The company has signed a deposit contract with V.P.S COMPANY LIMITED to lease a facility in Dong Nai Province, Vietnam, with a monthly rent of $63,840.15 for an initial term of 5 years [1] Group 2 - The company will continue to pay rent to V.P.S and other third parties for construction, decoration, and operational setup of the factory [2] - Due to pending approval for foreign direct investment (ODI), the company plans to sign an additional payment agreement with YARDCARE HONGKONG LIMITED to cover related expenses, with a maximum amount not exceeding 10 million RMB [2]

Group 1: Company Overview and Core Competencies - The company focuses on manufacturing anti-corrosion and wear-resistant welding equipment, with applications in energy, chemical, metallurgy, and paper industries [1] - It possesses key core technologies across materials, processes, and equipment, along with comprehensive special equipment production qualifications [1] - The management team has extensive industry experience and a stable core technical staff, contributing to the company's competitive edge [1] Group 2: Market Opportunities and Strategic Expansion - The company is actively expanding into overseas markets, particularly in the waste incineration and coal-fired power sectors, which show significant growth potential [2] - It has established a presence in the HRSG (Heat Recovery Steam Generator) and oil and gas composite pipe markets, with HRSG already having a certain scale of production capacity [2] - The company has three production bases globally, with significant manufacturing advantages and a successful expansion in Vietnam, where the factory has commenced operations [2] Group 3: Production Capacity and Investment Plans - The Vietnam base currently has 4 HRSG production lines, with plans to expand to 12 lines, with the second phase expected to be operational by next year [3][4] - The company is also establishing 2 HRSG production lines in the Daya base, projected to be operational by 2026, primarily serving non-North American markets [6] Group 4: Competitive Landscape and Strategic Positioning - Competitors in the Vietnam HRSG market include manufacturers from South Korea, Thailand, and Vietnam [6] - The company has a competitive advantage due to its extensive experience in the energy sector, comprehensive production qualifications, and established relationships with major gas turbine suppliers in North America [6] - The company aims to enhance its overall competitiveness and profitability through strategic overseas investments and partnerships, including a joint venture with Willham Company to explore oil and gas markets [7]

Core Viewpoint - Dige Pharmaceutical Co., Ltd. (stock code: 688192) announced plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and brand image [1] Group 1: Announcement Details - The second meeting of the second board of directors was held on December 24, 2025, where the proposal for issuing H-shares was approved [1] - The issuance aims to deepen the company's global strategic layout and improve its international brand image and core competitiveness [1] - The company will complete the issuance and listing within 24 months of the shareholders' meeting resolution or an extended period, subject to regulatory approvals [1] Group 2: Regulatory Compliance - The issuance must comply with the Company Law, Securities Law, and relevant regulations from the Hong Kong Stock Exchange and other regulatory bodies [1] - The company is actively discussing specific work related to the issuance with relevant intermediaries, although details such as the proposed share issuance ratio are yet to be determined [1]

转自：智通财经 【迪哲医药：拟发行H股股票并在香港联交所上市】《科创板日报》24日讯，迪哲医药(688192.SH)公告 称，公司于2025年12月24日召开第二届董事会第十八次会议，审议通过了《关于公司发行H股股票并在 香港联合交易所有限公司上市的议案》。公司拟发行境外上市外资股（H股）股票并在香港联交所主板 挂牌上市，以深化全球化战略布局，提升公司国际化品牌形象和核心竞争力。 ...

本文源自：金融界AI电报 迪哲医药公告，公司于2025年12月24日召开第二届董事会第十八次会议，审议通过了《关于公司发行H 股股票并在香港联合交易所有限公司上市的议案》。公司拟发行境外上市外资股（H股）股票并在香港 联合交易所有限公司主板挂牌上市，旨在深化全球化战略布局，提升公司国际化品牌形象和核心竞争 力。公司将根据相关法律法规进行本次发行并上市，并需取得中国证券监督管理委员会、香港联交所和 香港证券及期货事务监察委员会等相关政府部门、监管机构、证券交易所的批准或备案。 ...

迪哲医药(688192.SH)发布公告，为深化全球化战略布局，提升公司国际化品牌形象，进一步提升公司 核心竞争力，公司拟发行境外上市外资股(简称"H股")股票并在香港联合交易所有限公司(简称"香港联 交所")主板挂牌上市。 ...

Core Viewpoint - 威胜控股 has entered into a capital increase agreement with 博裕投资, which will enhance the financial strength and industry resources of its subsidiary, 惟远能源, through an investment of RMB 380 million for 48,810,742 new shares, representing approximately 8% of the enlarged share capital [1] Group 1 - The capital increase agreement is aimed at injecting capital and resources into 惟远能源 [1] - 博裕投资's extensive layout and cross-border investment experience will empower 威胜控股's business expansion and enhance market competitiveness [1] - The agreement supports the acceleration of 威胜控股's global strategic layout [1]

Core Viewpoint - The company, Shida Shenghua, announced plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and competitiveness [1] Group 1: Company Announcement - The company will hold a board meeting on December 23, 2025, to review the proposal for issuing H-shares [1] - The issuance aims to deepen the company's global strategic layout and create an international capital operation platform [1] - Specific details of the issuance are not finalized and require approval from shareholders, government departments, regulatory agencies, and the stock exchange [1] Group 2: Market Implications - The move is part of the company's strategy to improve its overall competitiveness in the market [1] - The announcement indicates a significant step towards internationalization and expansion in capital markets [1] - There is a notable uncertainty surrounding the proposal, which will be disclosed in a timely manner [1]

Core Viewpoint - The company maintains a global strategy and has successfully shifted its tire orders to overseas factories for production and shipment to the EU, mitigating potential negative impacts from the EU's anti-dumping policies against Chinese tires [1] Group 1 - The company has transferred nearly all of its tire orders destined for the EU to its overseas factories [1] - The implementation of the EU's double-reverse policy is not expected to adversely affect the company's order volume [1] - The company will closely monitor the progress of the relevant investigations by both parties [1]

Core Viewpoint - The company, Shida Shenghua (603026), aims to enhance its global strategy and competitiveness by applying for an initial public offering (IPO) of overseas listed foreign shares (H-shares) on the Hong Kong Stock Exchange [1] Group 1 - The company is advancing its globalization strategy to create an international capital operation platform [1] - The IPO is intended to improve the company's overall competitiveness in the market [1]